CD8A and neoplasm: In vivo experiments further demonstrated that inhibition of miR-4664-3p enhances CD8+ T cell infiltration and IFN-γ expression in tumor tissues, suggesting that miR-4664-3p may promote tumor progression by negatively regulating CD8+ T cell activity.